1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system
- PMID: 12122115
- PMCID: PMC151055
- DOI: 10.1172/JCI15219
1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system
Abstract
Inappropriate activation of the renin-angiotensin system, which plays a central role in the regulation of blood pressure, electrolyte, and volume homeostasis, may represent a major risk factor for hypertension, heart attack, and stroke. Mounting evidence from clinical studies has demonstrated an inverse relationship between circulating vitamin D levels and the blood pressure and/or plasma renin activity, but the mechanism is not understood. We show here that renin expression and plasma angiotensin II production were increased severalfold in vitamin D receptor-null (VDR-null) mice, leading to hypertension, cardiac hypertrophy, and increased water intake. However, the salt- and volume-sensing mechanisms that control renin synthesis are still intact in the mutant mice. In wild-type mice, inhibition of 1,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)] synthesis also led to an increase in renin expression, whereas 1,25(OH)(2)D(3) injection led to renin suppression. We found that vitamin D regulation of renin expression was independent of calcium metabolism and that 1,25(OH)(2)D(3) markedly suppressed renin transcription by a VDR-mediated mechanism in cell cultures. Hence, 1,25(OH)(2)D(3) is a novel negative endocrine regulator of the renin-angiotensin system. Its apparent critical role in electrolytes, volume, and blood pressure homeostasis suggests that vitamin D analogues could help prevent or ameliorate hypertension.
Figures
Comment in
-
Regulation of renin expression and blood pressure by vitamin D(3).J Clin Invest. 2002 Jul;110(2):155-6. doi: 10.1172/JCI16160. J Clin Invest. 2002. PMID: 12122105 Free PMC article. Review. No abstract available.
-
Discovery of vitamin D hormone as a negative regulator of the renin-angiotensin system.Clin Chem. 2014 Mar;60(3):561-2. doi: 10.1373/clinchem.2013.216150. Epub 2013 Dec 20. Clin Chem. 2014. PMID: 24363372 No abstract available.
References
-
- Ballermann, B.J., Zeidel, M.L., Gunning, M.E., and Brenner, B.M. 1991. Vasoactive peptides and the kidney. In The kidney. B.M. Brenner and F.C. Rector, editors. W.B. Saunders Co. Philadelphia, Pennsylvania, USA. 510–583.
-
- Hackenthal E, Paul M, Ganten D, Taugner R. Morphology, physiology, and molecular biology of renin secretion. Physiol Rev. 1990;70:1067–1116. - PubMed
-
- Ritthaler T, et al. Effects of endothelins on renin secretion from isolated mouse renal juxtaglomerular cells. Am J Physiol. 1995;268:F39–F45. - PubMed
-
- Shi Q, Gross KW, Sigmund CD. Retinoic acid-mediated activation of the mouse renin enhancer. J Biol Chem. 2001;276:3597–3603. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
